PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?

被引：13
|
作者：
Cainzos-Achirica, Miguel [1 ]
Martin, Seth S. [1 ]
Cornell, John E.
Murow, Cynthia D.
Guallar, Eliseo
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2015年 / 163卷 / 01期
关键词：
HYPERCHOLESTEROLEMIA; LDL;
D O I：
10.7326/M15-0920
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：64 / 65
页数：2
相关论文
共 50 条
  • [21] PCSK9 Inhibitors: The Next Frontier in Low-Density Lipoprotein Lowering
    Jialal, Ishwarlal
    Patel, Shailendra B.
    METABOLIC SYNDROME AND RELATED DISORDERS, 2015, 13 (03) : 99 - 101
  • [22] PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDL-Cholesterol
    Wang, Yan
    Liu, Zhao-Peng
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2019, 19 (02) : 165 - 176
  • [23] A New Approach to PCSK9 Therapeutics
    Wang, Nan
    Tall, Alan R.
    CIRCULATION RESEARCH, 2017, 120 (07) : 1063 - 1065
  • [24] PCSK9 inhibitors for treating hypercholesterolemia
    Pasta, Andrea
    Cremonini, Anna Laura
    Pisciotta, Livia
    Buscaglia, Angelo
    Porto, Italo
    Barra, Fabio
    Ferrero, Simone
    Brunelli, Claudio
    Rosa, Gian Marco
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (03) : 353 - 363
  • [25] Are PCSK9 Inhibitors Cost Effective?
    Korman, Max J.
    Retterstol, Kjetil
    Kristiansen, Ivar Sonbo
    Wisloff, Torbjorn
    PHARMACOECONOMICS, 2018, 36 (09) : 1031 - 1041
  • [26] Current treatment of dyslipidaemia: PCSK9 inhibitors and statin intolerance
    Koskinas, Konstantinos C.
    Wilhelm, Matthias
    Windecker, Stephan
    SWISS MEDICAL WEEKLY, 2016, 146 : w14333
  • [27] A Comprehensive Review of PCSK9 Inhibitors
    Coppinger, Caroline
    Movahed, Mohammad Reza
    Azemawah, Veronica
    Peyton, Lee
    Gregory, James
    Hashemzadeh, Mehrnoosh
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 27
  • [28] Combined intake of glucose-and lipid-lowering medications further elevates plasma levels of PCSK9 in type 2 diabetes patients
    Awadallah, Samir
    Taneera, Jalal
    Mohammed, Abdul Khader
    Unnikannan, Hema
    Sulaiman, Nabil
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (06) : 2087 - 2092
  • [29] The Anti-Thrombotic Effects of PCSK9 Inhibitors
    Pec, Martin Jozef
    Benko, Jakub
    Jurica, Jakub
    Pecova, Monika
    Samec, Marek
    Hurtova, Tatiana
    Bolek, Tomas
    Galajda, Peter
    Pec, Martin
    Samos, Matej
    Mokan, Marian
    PHARMACEUTICALS, 2023, 16 (09)
  • [30] Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and the Future of Lipid Lowering Therapy
    Joseph, Lee
    Robinson, Jennifer G.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2015, 58 (01) : 19 - 31
12345